Botulinum toxin treatment of axial and cervical dystonia

被引：36

作者：

Benecke, Reiner ^{[1
]}

Dressler, Dirk ^{[1
]}

机构：

[1] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany

来源：

DISABILITY AND REHABILITATION | 2007年 / 29卷 / 23期

关键词：

botulinum toxin; axial dystonia; cervical dystonia; SELECTIVE PERIPHERAL DENERVATION; DOUBLE-BLIND; SPASMODIC TORTICOLLIS; CONTROLLED TRIAL; INJECTIONS; EFFICACY; SAFETY;

D O I：

10.1080/01421590701568262

中图分类号：

R49 [康复医学];

学科分类号：

100215 ;

摘要：

Axial truncal dystonia is characterized by an abnormal trunk posture often superimposed by myoclonic motor activities. Cervical dystonia is a motor syndrome characterized by abnormal head and neck posture due to tonic involuntary contractions in a certain set of muscles often superimposed by myoclonic or tremolous movements. Intramuscular injection of botulinum toxin is the first line treatment in cervical dystonia, in axial truncal dystonias botulinum toxin therapy is used only in mild forms. In this review the theoretical background, practical aspects and efficacy results especially in cervical dystonia are presented. Treatment of axial trunk dystonia is only briefly discussed at the beginning of this review.

引用

页码：1769 / 1777

页数：9

共 40 条

[31] A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia [J].

Naumann, M ;

Yakovleff, A ;

Durif, F .

JOURNAL OF NEUROLOGY, 2002, 249 (01) :57-63

[32] Mexiletine in the treatment of spasmodic torticollis [J].

Ohara, S ;

Hayashi, R ;

Momoi, H ;

Miki, J ;

Yanagisawa, N .

MOVEMENT DISORDERS, 1998, 13 (06) :934-940

[33] TREATMENT OF SPASMODIC TORTICOLLIS WITH LOCAL INJECTIONS OF BOTULINUM TOXIN - ONE-YEAR FOLLOW-UP IN 37 PATIENTS [J].

POEWE, W ;

SCHELOSKY, L ;

KLEEDORFER, B ;

HEINEN, F ;

WAGNER, M ;

DEUSCHL, G .

JOURNAL OF NEUROLOGY, 1992, 239 (01) :21-25

[34] CASE 1, 1987 - UNUSUAL TREMORS, BRADYKINESIA, AND CEREBRAL LUCENCIES [J].

SHALE, H ;

FAHN, S ;

KOLLER, WC ;

LANG, AE .

MOVEMENT DISORDERS, 1987, 2 (04) :321-338

[35] BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS [J].

STELL, R ;

THOMPSON, PD ;

MARSDEN, CD .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (07) :920-923

[36] CLOZAPINE TREATMENT OF SPASMODIC TORTICOLLIS [J].

THIEL, A ;

DRESSLER, D ;

KISTEL, C ;

RUTHER, E .

NEUROLOGY, 1994, 44 (05) :957-958

[37] A PILOT-STUDY ON THE USE OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS [J].

TSUI, JK ;

EISEN, A ;

MAK, E ;

CARRUTHERS, J ;

SCOTT, A ;

CALNE, DB .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (04) :314-316

[38]

TSUI JKC, 1986, LANCET, V2, P245

[39]

Wissel J, 1992, J Neural Transm Suppl, V38, P91

[40] BOTULINUM ANTIBODIES IN DYSTONIC PATIENTS TREATED WITH TYPE-A BOTULINUM TOXIN - FREQUENCY AND SIGNIFICANCE [J].

ZUBER, M ;

SEBALD, M ;

BATHIEN, N ;

DERECONDO, J ;

RONDOT, P .

NEUROLOGY, 1993, 43 (09) :1715-1718

← 1 2 3 4 →